{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:57:44Z","timestamp":1777777064267,"version":"3.51.4"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The aim of this study was to compare the frequency of sarcopenia, functional status, fear-avoidance behaviors, biopsychosocial status and quality of life in RA women with healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>25 RA women and 25 healthy women were included in the study. Definition of sarcopenia was assessed using parameters recommended by the European Working Group on Sarcopenia (EWGSOP): Bioimpedance analysis for muscle mass (body fat ratio, skeletal muscle mass, skeletal muscle mass index); grip and knee extension strength for muscle strength and 4-m course gait speed test for physical performance was applied. Functional status was evaluated with the Health Assessment Questionnaire (HAQ), fear-avoidance behaviors with the Tampa Kinesiophobia Scale (TKS), biopsychosocial status with the Biopsychosocial Questionnaire (BETY-BQ), and quality of life with Short Form-36 (SF-36).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While none of the healthy women had sarcopenia, severe sarcopenia was detected in 7 (28%) of the women with RA. When RA and healthy groups were compared; skeletal muscle mass (p: 0,004); skeletal muscle mass index (p: 0,011); grip strength-right (p:0.001) and left (p:0.001); knee extension strength-right (p:0.001) and left (p:0.001), 4-m course gait speed test (p:0.001), HAQ (p:0.001), TKS (p:0.001), BETY-BQ (p:0.001), SF-36 physical (p:0.001) ve mental component (p:0.001) results were significant in favor of the healthy group while there was no difference in body fat ratio (p&gt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In women with RA, the frequency of sarcopenia is higher, and functional status, fear-avoidance behaviors, biopsychosocial status and quality of life are worse than healthy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/rjim-2023-0036","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T12:51:00Z","timestamp":1703767860000},"page":"150-159","source":"Crossref","is-referenced-by-count":1,"title":["Examining the presence of sarcopenia in women with rheumatoid arthritis: Case-control study"],"prefix":"10.2478","volume":"62","author":[{"given":"Begum","family":"Akar","sequence":"first","affiliation":[{"name":"Faculty of Physiotherapy and Rehabilitation , Pamukkale University , Denizli , Turkey ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge Basakci","family":"Calik","sequence":"additional","affiliation":[{"name":"Faculty of Physiotherapy and Rehabilitation , Pamukkale University , Denizli , Turkey ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Gur","family":"Kabul","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Physiotherapy and Rehabilitation , Usak University , Usak , Turkey ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Nur Bayindir","family":"Akba\u015f","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical Faculty , Pamukkale University , Denizli , Turkey ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veli","family":"Cobankara","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical Faculty , Pamukkale University , Denizli , Turkey ."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"2026042915195190658_j_rjim-2023-0036_ref_001","doi-asserted-by":"crossref","unstructured":"ALETAHA D, NEOG\u0130 T, S\u0130LMAN AJ, FUNOV\u0130TS J, FELSON DT, B\u0130NGHAM III CO, ET AL. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9): 2569-2581.","DOI":"10.1002\/art.27584"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_002","doi-asserted-by":"crossref","unstructured":"GRAVALLESE EM, F\u0130RESTE\u0130N GS. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med. 2023;388(6):529-542.","DOI":"10.1056\/NEJMra2103726"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_003","doi-asserted-by":"crossref","unstructured":"SCHERER HU, HAUPL T, BURMESTER GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110: 102400.","DOI":"10.1016\/j.jaut.2019.102400"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_004","doi-asserted-by":"crossref","unstructured":"YANG J, LI Q. Rheumatoid Arthritis. N Engl J Med. 2023;388(20):1919.","DOI":"10.1056\/NEJMc2302868"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_005","doi-asserted-by":"crossref","unstructured":"ALIVERNINI S, FIRESTEIN GS, McINNES IB. The pathogenesis of rheumatoid arthritis. Immunity. 2022;55(12):2255-2270.","DOI":"10.1016\/j.immuni.2022.11.009"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_006","doi-asserted-by":"crossref","unstructured":"YUAN S, LARSSON SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.","DOI":"10.1016\/j.metabol.2023.155533"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_007","doi-asserted-by":"crossref","unstructured":"VOGELE D, OTTO S, SOLLMANN N, HAGGENM\u00dcLLER B, WOLF D, BEER M, SCHM\u0130DT SA. Sarcopenia - Definition, Radiological Diagnosis, Clinical Significance. Rofo. 2023;195(5):393-405.","DOI":"10.1055\/a-1990-0201"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_008","doi-asserted-by":"crossref","unstructured":"CRUZ-JENTOFT AJ, BAEYENS JP, BAUER JM, BO\u0130R\u0130E Y, CEDERHOLM T, LAND\u0130 F, ET AL. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-423.","DOI":"10.1093\/ageing\/afq034"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_009","doi-asserted-by":"crossref","unstructured":"WU D, LUO Y, LI T, ZHAO X, LV T, FANG G, et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022 Dec 22;13:1051082.","DOI":"10.3389\/fimmu.2022.1051082"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_010","doi-asserted-by":"crossref","unstructured":"BANO G, TREV\u0130SAN C, CARRARO S, ET AL. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017; 96: 10-15.","DOI":"10.1016\/j.maturitas.2016.11.006"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_011","doi-asserted-by":"crossref","unstructured":"RALL LC, ROUBENOFF R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions Rheumatology. 2004; 43(10): 1219-23.","DOI":"10.1093\/rheumatology\/keh321"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_012","doi-asserted-by":"crossref","unstructured":"NGEULEU A, ALLAL\u0130 F, MEDRARE L, MADH\u0130 A, RKA\u0130N H, HAJJAJ-HASSOUN\u0130 N. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int. 2017; 37(6): 1015-1020.","DOI":"10.1007\/s00296-017-3665-x"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_013","doi-asserted-by":"crossref","unstructured":"BAHAT G, TUFAN A, TUFAN F, K\u0130L\u0130C C, AKP\u0130NAR TS, KOSE M, ET AL. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016; 35(6): 1557-63.","DOI":"10.1016\/j.clnu.2016.02.002"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_014","doi-asserted-by":"crossref","unstructured":"ROBERTS HC, DEN\u0130SON HJ, MART\u0130N HJ, PATEL HP, SYDDALL H, COOPER C, SAYER AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011; 40(4): 423-9","DOI":"10.1093\/ageing\/afr051"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_015","doi-asserted-by":"crossref","unstructured":"TRUDELLE-JACKSON E, JACKSON AW, FRANKOWSK\u0130 CM, LONG KM, MESKE NB. Interdevice Reliability and Validity Assessment Of The Nicholas Hand-Held Dynamometer. J Orthop Sports Phys Ther. 1994; 20: 302-6.","DOI":"10.2519\/jospt.1994.20.6.302"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_016","unstructured":"FR\u0130ES JF, SP\u0130TZ PW, YOUNG DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789-93."},{"key":"2026042915195190658_j_rjim-2023-0036_ref_017","doi-asserted-by":"crossref","unstructured":"VLAEYEN JWS, KOLE-SN\u0130JDERS AMJ, ROTTEVEEL AM, ET AL. The role of fear of movement\/(re)injury in pain disability. J Occup Rehab. 1995; 5(4): 235-252.","DOI":"10.1007\/BF02109988"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_018","unstructured":"KUMBARO\u011eLU FB, KARAKAYA KARABULUT J, APRA\u015e B\u0130LGEN \u015e, \u00dcNAL E. Determination of the validity, reliability, and sensitivity of the BETY- Biopsychosocial Questionnaire in patients with a diagnosis of rheumatoid arthritis. JETR. 2021; 8(1): 90-98."},{"key":"2026042915195190658_j_rjim-2023-0036_ref_019","doi-asserted-by":"crossref","unstructured":"WARE JE JR, SHERBOURNE CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30 (6): 473-83.","DOI":"10.1097\/00005650-199206000-00002"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_020","doi-asserted-by":"crossref","unstructured":"TEKGOZ E, COLAK S, OZALP ATES FS, SONAEREN I, Y\u0130LMAZ S, C\u0130NAR M. Sarcopenia in rheumatoid arthritis: Is it a common manifestation? Int J Rheum Dis. 2020; 23(12): 1685\u20131691.","DOI":"10.1111\/1756-185X.13976"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_021","doi-asserted-by":"crossref","unstructured":"AM\u0130NOV K. Sarcopenia and osteoporosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2017; 76: 1351","DOI":"10.1136\/annrheumdis-2017-eular.3165"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_022","doi-asserted-by":"crossref","unstructured":"RE\u0130NA D, G\u00d3MEZ-VAQUERO C, D\u00cdAZ-TORN\u00c9 C, SOL\u00c9 JMN. Assessment of nutritional status by dual X-Ray absorptiometry in women with rheumatoid arthritis: A case-control study. Medicine (Baltimore). 2019; 98(6): e14361.","DOI":"10.1097\/MD.0000000000014361"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_023","doi-asserted-by":"crossref","unstructured":"DAO HH, DO QT, SAKAMOTO J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology. 2011; 50(7): 1250-8.","DOI":"10.1093\/rheumatology\/ker004"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_024","doi-asserted-by":"crossref","unstructured":"DO\u011eAN SC, H\u0130ZMETL\u0130 S, HAYTA E, KAPTANO\u011eLU E, ERSELCAN T, G\u00dcLER E. Sarcopenia in women with rheumathoid arthritis. Eur J Rheumatol. 2015; 2(2): 57\u201361.","DOI":"10.5152\/eurjrheum.2015.0038"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_025","doi-asserted-by":"crossref","unstructured":"ALKAN-MEL\u0130KO\u011eLU M. Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Arch Rheumatol. 2017; 32(1): 53-59.","DOI":"10.5606\/ArchRheumatol.2017.6078"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_026","doi-asserted-by":"crossref","unstructured":"TADA M, YAMADA Y, MANDA\u0130 K, H\u0130DAKA N. Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis-results from the CHIKARA study. Int J Rheum Dis. 2018; 21(11): 1962-1969.","DOI":"10.1111\/1756-185X.13335"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_027","doi-asserted-by":"crossref","unstructured":"KEEFE FJ, SM\u0130TH SJ, BUFF\u0130NGTON AL, ET AL. Recent advances and future directions in the biopsychosocial assessment and treatment of arthritis. J Consult Clin Psychol. 2002; 70(3): 640-655.","DOI":"10.1037\/\/0022-006X.70.3.640"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_028","unstructured":"UHL\u0130G T, LOGE JH, KR\u0130ST\u0130ANSEN IS, ET AL. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007; 34(6): 1241-1247."},{"key":"2026042915195190658_j_rjim-2023-0036_ref_029","doi-asserted-by":"crossref","unstructured":"LEE MK, JEONG HH, K\u0130M MJ, RYU H, BAEK J, LEE B. Nutrients against Glucocorticoid-Induced Muscle Atrophy. Foods. 2022;11(5):687.","DOI":"10.3390\/foods11050687"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_030","doi-asserted-by":"crossref","unstructured":"HEIN TR, PETERSON L, BARTIKOSKI BJ, PORTES J, ESPIRITO SANTO RC, XAVIER RM. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis. Arthritis Res Ther. 2022;24(1):171.","DOI":"10.1186\/s13075-022-02932-5"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_031","doi-asserted-by":"crossref","unstructured":"YAMADA Y, TADA M, MANDAI K. HIDAKA N, INUI K, NAKAMURA H. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin Rheumatol. 2020;39:1757\u20131764.","DOI":"10.1007\/s10067-020-04929-4"},{"key":"2026042915195190658_j_rjim-2023-0036_ref_032","doi-asserted-by":"crossref","unstructured":"MOSCHOU D, KRIKELIS M, GEORGAKOPOULOS C, MOLE E, CHRONOPOULOS E, TOURNIS S, et al. Sarcopenia in Rheumatoid arthritis. A narrative review. J Frailty Sarcopenia Falls. 2023;8(1):44-52.","DOI":"10.22540\/JFSF-08-044"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2023-0036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:43:53Z","timestamp":1777488233000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2023-0036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12,28]]},"published-print":{"date-parts":[[2024,6,1]]}},"alternative-id":["10.2478\/rjim-2023-0036"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2023-0036","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}